|
| Press Releases |
|
 |
|
| Wednesday, September 8, 2021 |
|
|
阿诺医药宣布AN2025、AN0025与atezolizumab三联治疗晚期实体瘤1a期临床在美国完成首例患者给药 |
阿诺医药，一家专注于肿瘤治疗领域的创新型全球生物制药公司，今日宣布其口服泛PI3K抑制剂buparlisib（AN2025）、口服EP4拮抗剂（AN0025）与PD-L1抑制剂atezolizumab（阿替利珠单抗）三联疗法在晚期/转移性实体瘤患者中开展的Ia期临床试验已于美国成功完成首例患者给药。
more info >> |
|
|
阿諾醫藥宣佈AN2025、AN0025與atezolizumab三聯治療晚期實體瘤1a期臨床在美國完成首例患者給藥 |
| 阿諾醫藥，一家專注於腫瘤治療領域的創新型全球生物製藥公司，今日宣佈其口服泛PI3K抑制劑buparlisib（AN2025）、口服EP4拮抗劑（AN0025）與PD-L1抑制劑atezolizumab（阿替利珠單抗）三聯療法在晚期/轉移性實體瘤患者中開展的Ia期臨床試驗已于美國成功完成首例患者給藥。 more info >> |
|
|
Adlai Nortye Announces First Patient Dosed in Phase Ia Clinical Trial of AN2025 and AN0025 in Combination with atezolizumab for Advanced Solid Tumors |
| Adlai Nortye, a global biopharmaceutical company focused on developing innovative oncology drugs, today announced that the first patient has been dosed in the Phase Ia clinical trial in the U.S. to evaluate the triple combination of AN2025 (buparlisib, oral pan-PI3K inhibitor), AN0025 (oral EP4 antagonist) and atezolizumab (PD-L1 inhibitor) in patients with locally advanced/metastatic tumors. more info >> |
|
| Thursday, July 15, 2021 |
|
|
Adlai Nortye Raises $100 Million in Series D Financing, Co-led by SDIC Fund Management and Tigermed, participated by Legend Star, WuXi Biologics Healthcare Ventures |
| Adlai Nortye Ltd. (hereinafter referred to as "Adlai Nortye"), a global biopharmaceutical company focused on developing innovative oncology drugs, today announced the completion of $100 million Series D financing round. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Habitat for Humanity Asia-Pacific joins global 'Let's Open the Door' campaign to spotlight housing need
Apr 3, 2026 03:06: JST
|
|
|
Driving Malaysia's Energy Transition: Solar & Storage Live Malaysia 2026 Returns to Kuala Lumpur
Apr 3, 2026 03:01: JST
|
|
|
OMRON Healthcare and UCSF launch AFib trial
Apr 2, 2026 0:00 JST
|
|
|
U.S. Polo Assn. 贊助第一級全國大學馬球錦標賽，展現馬球運動的未來
Apr 2, 2026 19:00 HKT/SGT
|
|
|
U.S. Polo Assn. 赞助第一级全国大学马球锦标赛，展现马球运动的未来
Apr 2, 2026 19:00 HKT/SGT
|
|
|
U.S. Polo Assn. Supports Division I National Intercollegiate Championship, Showcasing the Future of the Sport of Polo
Apr 2, 2026 19:00 HKT/SGT
|
|
|
Founders Metals Makes First Discovery at Antino North; Drills 17.22 g/t Au over 3.6 m within 24.6 m of 2.81 g/t Au
Apr 2, 2026 18:59 HKT/SGT
|
|
|
DENSO and FoodVentures Strengthen Collaboration through Capital Partnership in the Agricultural Sector
Apr 2, 2026 19:56 JST
|
|
|
天數智芯推理业务大增238.2% 1000+项目验证 商業化加速落地
Apr 2, 2026 18:06 HKT/SGT
|
|
|
天数智芯推理业务大增238.2% 1000+项目验证 商业化加速落地
Apr 2, 2026 18:01 HKT/SGT
|
|
|
核心主業增長149.6% 推理業務大增238.2% 天數智芯2025年交出亮眼答卷
Apr 2, 2026 17:49 HKT/SGT
|
|
|
核心主业增长149.6% 推理业务大增238.2% 天数智芯2025年交出亮眼答卷
Apr 2, 2026 17:44 HKT/SGT
|
|
|
豪華新能源車企賽力斯營收破千億 高研發投入下的盈利與未來布局
Apr 2, 2026 17:20 HKT/SGT
|
|
|
豪华新能源车企赛力斯营收破千亿 高研发投入下的盈利与未来布局
Apr 2, 2026 17:14 HKT/SGT
|
|
|
Luxury NEV Enterprise Seres Hits Record High Revenue of RMB164.89 Billion in 2025, Maintaining Positive Profitability for Second Consecutive Year
Apr 2, 2026 17:09: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
